首页 | 本学科首页   官方微博 | 高级检索  
检索        

胰腺癌p16、Bcl-2、Bax和VEGF基因表达及新生血管密度计数的意义
引用本文:盖宝东,高福智,李晓娜,房学东,郑泽霖.胰腺癌p16、Bcl-2、Bax和VEGF基因表达及新生血管密度计数的意义[J].吉林大学学报(医学版),2005,31(1):94-96.
作者姓名:盖宝东  高福智  李晓娜  房学东  郑泽霖
作者单位:吉林大学中日联谊医院基本外科,吉林,长春,130031;解放军第461医院普通外科,吉林,长春,130021
基金项目:日本国东北大学校科研和教改项目
摘    要:目的:研究胰腺癌组织中p16、Bcl-2、Bax和VEGF基因的表达及新生血管计数的意义。 方法:采用免疫组织化学法及形态半定量方法对33例胰腺癌和6例正常胰腺组织进行新生血管密度记数和p16、Bcl-2、Bax和VEGF基因表达检测。 结果:P16蛋白表达:高、中分化胰腺癌高于低分化(P<0.05),生存期长者表达高于生存期短者(P<0.05);Bcl-2表达:高、中分化者高于低分化者;Bax表达:正常胰腺组织高于胰腺瘤组织,高、中分化者高于低分化者,生存期≥12个月者高于<12个月者;VEGF表达:有淋巴结转移者高于无淋巴结转移者;MVD记数:正常胰腺组织低于胰腺瘤组织,有淋巴转移者高于无淋巴结转移者;MVD与VEGF表达呈正相关(r=0.79,P<0.05);p16基因表达与VEGF表达和MVD呈负相关(r=-0.69,P<0.05;r=-0.87,P<0.05),Bcl-2表达与其他基因表达结果无相关关系。Bax表达与p16表达呈正相关(r=0.54,P<0.05),与VEGF表达和MVD呈负相关(r=-0.66,P<0.05)。 结论:综合检测胰腺癌组织中p16、Bcl-2、Bax和VEGF基因的表达及微血管密度对判断胰腺癌恶性程度及估计肿瘤的预后有较大帮助。

关 键 词:胰腺肿瘤/遗传学  基因  p53  Bcl-2  Bax  内皮生长因子/遗传学  新生血管密度
文章编号:1671-587X(2005)01-0094-04
收稿时间:2004-01-12
修稿时间:2004年1月12日

Expressions of p16, Bcl-2, Bax, and VEGF and significance of microvessel density in human pancreatic cancer
GAI Bao-dong ,GAO Fu-zhi ,LI Xiao-na ,FANG Xue-dong ,ZHENG Ze-lin.Expressions of p16, Bcl-2, Bax, and VEGF and significance of microvessel density in human pancreatic cancer[J].Journal of Jilin University: Med Ed,2005,31(1):94-96.
Authors:GAI Bao-dong  GAO Fu-zhi  LI Xiao-na  FANG Xue-dong  ZHENG Ze-lin
Institution:1. Department of General Surgery, China-Japan Union Hospital, Jilin University, Changchun 130031, China;2. Department of General Surgery, No. 461 Hospital of PLA, Changchun 130021, China
Abstract:Objective To study the expressions of p16, Bcl-2, Bax, VEGF and significance of microvessel density(MVD) in human pancreatic cancer. Methods Immunohistochemistry method and morphological semi-quantitative analysis were used to detect the quantity of MVD and the expressions of p16,Bcl-2,Bax, and VEGF in 33 cases of pancreatic cancer and 6 normal pancreas tissue specimen. Results The expression of P16 protein: it was higher in moderately or well differentiated pancreatic adenocarcinoma than poorly one (P<0.05), it was higher in patient with long survial time than those with short survial time (P<0.05);the expression of Bcl-2: it was higher in moderately or well differentiated pancreatic adenocarcinoma than poorly one; the expression of Bax:it was higher in normal pancreatic tissue than pancreatic cancer, as well as moderately or well differentiated than poorly one and survival time≥12 months than <12 months; the expression of VEGF:it was higher in patients with lymph node metastasis than without lymph node metastasis; MVD count: it was lower in normal pancreatic tissue than pancreatic cancer as well as with lymph node metastasis than without lymph node metastasis; the expression of MVD had positive correlation with VEGF expression (r=0.79,P<0.05);p16 gene expression had negative correlation with VEGF expression and MVD (r=-0.69,P<0.05;r=-0.87,P<0.05),but Bcl-2expression had no correlation with other gene expressions. Bax expression had positive correlation with p16 gene expresion (r=0.54,P<0.05),and had negative correlation with VEGF expression and MVD(r=-0.66, P<0.05). Conclusion The determination of p16, Bcl-2, Bax, VEGF expressions and MVD in human pancreatic cancer may be used to evaluate the prognosis and judge the differentiation of the adenocarcinoma.
Keywords:panacreatic neoplasms/genetics  genes  p53  genes  Bcl-2  Bax  endothelial growth factors/genetics  microvessel density
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《吉林大学学报(医学版)》浏览原始摘要信息
点击此处可从《吉林大学学报(医学版)》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号